Jessica M Nguyen1, Janet T Holbrook2, Christine Y Wei2, Lynn B Gerald3, W Gerald Teague4, Robert A Wise5. 1. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md. 2. Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Md. 3. Department of Health Promotion Sciences, University of Arizona College of Public Health, Tucson, Ariz. 4. Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Va. 5. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: rwise@jhmi.edu.
Abstract
BACKGROUND: The Asthma Control Questionnaire (ACQ) is a patient-centered tool for evaluating asthma control. It has been validated in adults, but not well-validated among children. OBJECTIVE: We evaluated the reliability, validity, and responsiveness to change of the ACQ for assessing asthma control in children ages 6 to 17 years. A threshold value for poor disease control and a minimally important difference were also determined. METHODS: Data from 305 asthmatic children enrolled in a clinical trial were examined. The ACQ was administered at 8 visits. We analyzed results for the combined age group and for the 6- to 11-year-old and 12- to 17-year-old age groups separately. RESULTS: Overall, the Cronbach α value (internal consistency) for the ACQ was 0.74 at baseline, and the intraclass correlation coefficient (test-retest reliability) for repeated questionnaires among stable patients was 0.53. The Pearson correlations between the ACQ and other asthma questionnaires were moderate to strong (-0.64 to -0.73). Mean ACQ scores were higher (worse) in patients whose peak flow decreased, who used more rescue medications, or who sought medical care for asthma than in patients who were stable (P < .0001 for all measures). Changes in ACQ scores were significantly different among patients with deteriorating, improving, or stable asthma symptoms (P ≤ .01). The optimal threshold indicating poor asthma control was 1.25 or greater. The minimally important difference was established to be 0.40. Results for the separate age groups were similar. CONCLUSION: The ACQ is a moderately reliable, valid, and responsive tool with adequate psychometric properties for assessing recent asthma control among children.
BACKGROUND: The Asthma Control Questionnaire (ACQ) is a patient-centered tool for evaluating asthma control. It has been validated in adults, but not well-validated among children. OBJECTIVE: We evaluated the reliability, validity, and responsiveness to change of the ACQ for assessing asthma control in children ages 6 to 17 years. A threshold value for poor disease control and a minimally important difference were also determined. METHODS: Data from 305 asthmatic children enrolled in a clinical trial were examined. The ACQ was administered at 8 visits. We analyzed results for the combined age group and for the 6- to 11-year-old and 12- to 17-year-old age groups separately. RESULTS: Overall, the Cronbach α value (internal consistency) for the ACQ was 0.74 at baseline, and the intraclass correlation coefficient (test-retest reliability) for repeated questionnaires among stable patients was 0.53. The Pearson correlations between the ACQ and other asthma questionnaires were moderate to strong (-0.64 to -0.73). Mean ACQ scores were higher (worse) in patients whose peak flow decreased, who used more rescue medications, or who sought medical care for asthma than in patients who were stable (P < .0001 for all measures). Changes in ACQ scores were significantly different among patients with deteriorating, improving, or stable asthma symptoms (P ≤ .01). The optimal threshold indicating poor asthma control was 1.25 or greater. The minimally important difference was established to be 0.40. Results for the separate age groups were similar. CONCLUSION: The ACQ is a moderately reliable, valid, and responsive tool with adequate psychometric properties for assessing recent asthma control among children.
Authors: Jason E Lang; Janet T Holbrook; Edward B Mougey; Christine Y Wei; Robert A Wise; W Gerald Teague; John J Lima Journal: Ann Am Thorac Soc Date: 2015-06
Authors: Jason E Lang; Edward B Mougey; Md Jobayer Hossain; Floyd Livingston; P Babu Balagopal; Scott Langdon; John J Lima Journal: Ann Am Thorac Soc Date: 2019-05
Authors: Molly A Martin; Valerie G Press; Kim Erwin; Helen Margellos-Anast; Stacy Ignoffo; Kate Sheridan McMahon; Giselle Mosnaim; Jessica Ramsay; S Margaret Paik Journal: J Asthma Date: 2017-07-18 Impact factor: 2.515
Authors: Christine James; David I Bernstein; Jennie Cox; Patrick Ryan; Christopher Wolfe; Roman Jandarov; Nicholas Newman; Reshmi Indugula; Tiina Reponen Journal: Indoor Air Date: 2019-12-08 Impact factor: 5.770
Authors: Sally M Weinstein; Oksana Pugach; Genesis Rosales; Giselle S Mosnaim; Surrey M Walton; Molly A Martin Journal: Pediatrics Date: 2019-07-09 Impact factor: 7.124